Quote:
Originally Posted by curlyface
Rafiki, since you seem to know a lot about it, thoughts on NTS.V? Like the idea and see some catalysts in India/"Asian country" contracts but seems like they're running into some product issues that are taking far longer than expected to iron out. Had a pop a recently but not sure what to make of it. Also, what's with the tactical training business? Seems like two pretty random business lines to combine?
I wouldn't really look for more confirmation than what Ahnuld has already revealed in here plus the charts. Commercials met with them, loved the story, volume opens wide up and we've been running ever since. Institutions who could have sold their 1.30's have not. On the short term there's no real reason to expect a big beat on earnings now as it's most likely priced in. So if you're asking this as a trader, I don't really know what to tell you, probably a bit more upside. If you're asking as an investor then almost all of the growth is ahead.
Tactical is moot and next call we probably find out it's done (which is good).
The Chinese issue lies more with how the bank note is produced than anything else. China wanted an exact duplicate despite it being different tech. The tech is implemented in the Chinese bank note presses, and you can't just turn them off according to Doug. So you get small windows to try your interative test and if it fails, you're back to the drawing board until the next time the presses are off. My guess is it's either this call or the next that they announce it's printing and then they're gold for 5 years+. And since they're finally cash-flow positive, frankly I don't really care if we get the good news this Q, the next, or even the one after.
I think the only interesting question with them now is what happens once they double revenues twice from here (as they've predicted). Where is their next growth story? They'll have something like 5 countries from the G20 and the Euro and probably the World Cup as high profile clients to back their tech (and I believe they'd be a historic first penetrating into China). The ones who gave them initial deals probably have no reason to not expand those. But beyond bank notes and tax stamps where's the next breakthrough? I don't know. Pharmaceuticals would be nice, far nicer than luxury goods based on the number of units out there. I've also never sat and done the circulation numbers for bank notes, and what a realistic ceiling is for their market share of it. Maybe that alone is enough to multi-bag.